Interviews

Tom Frank, PharmD, BCPS, Director or Research and Education at the University of Arkansas for Medical Sciences discusses the role of new digital technologies in the management of type 2 diabetes.

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses trends in specialty drug cost management.

Cheryl Allen, vice president of Industry Relations at Diplomat Specialty Pharmacy, discusses the elements of an effective, high touch patient care program.

Sheila Arquette, RPh, discusses optimal patient support programs in specialty pharmacy.

At the Pharmacy Quality Alliance annual meeting in Baltimore, Maryland, Eleanor Perfetto, PhD, MS, Senior Vice President for Strategic Initiatives at the National Health Council, spoke with Pharmacy Times about how health systems are taking a more patient-centered approach.

Mark A. Vineis, vice president of specialty pharmacy at Cardinal Health, discusses how communication can be improved among manufacturers, pharmacy benefit managers, and specialty pharmacies.

In this clip, Crystal Lennartz, PharmD, MBA, Chief Pharmacist at Health Mart, discusses what steps pharmacies can take to prepare for value-based health systems.

Cheryl Allen, vice president of Industry Relations at Diplomat, discusses the impact of direct and indirect remuneration fees on specialty pharmacy.

Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses how specialty stakeholders can improve clinical and financial alignment.

In this clip, Jennifer Strohecker, PharmD, BCPS, Sr. Director MHI Pharmacy, Clinical Operations, Molina Healthcare, Inc. discusses the challenges involved in treating patients with hepatitis C.

In this clip, Jennifer Strohecker, PharmD, BCPS, who is Senior Director MHI Pharmacy, Clinical Operations, discusses a high touch model of care.

At the 12th annual meeting of the Pharmacy Quality Alliance held recently in Baltimore, Maryland, several speakers shared ideas on converting patient input into meaningful performance measures.

Jonathan Van Lare, PharmD, director of Pharmacy Advantage, discusses the growth of biosimilars in specialty pharmacy.

Cheryl Allen, vice president of Industry Relations at Diplomat, discusses how specialty pharmacies can differentiate themselves from the competition.

Sheila Arquette, RPh, director of Pharmacy Services at Independent Health, discusses how specialty pharmacists can help patients manage adverse events from their treatment regimen.

Gregory R. Morris, chief commercial officer at VirMedica, discusses the eAccess program for specialty pharmacies.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses how specialty pharmacies help advance the goals of accountable care organizations.

Cheryl Allen, vice president of Industry Relations at Diplomat, discusses the largest challenges currently facing independent specialty pharmacies.

Mary M. Bridgeman, PharmD, BCPS, CGP, FASCP, clinical associate profession at the Ernesto Mario School of Pharmacy, Rutgers University, explains how pharmacy schools can optimize OTC training for students.

Mary M. Bridgeman, PharmD, BCPS, CGP, FASCP, clinical associate professor at the Ernesto Mario School of Pharmacy, Rutgers University, discusses whether pharmacy schools provide adequate OTC training.

Mary M. Bridgeman, PharmD, BCPS, CGP, FASCP, clinical associate professor at the Ernesto Mario School of Pharmacy, Rutgers University, discusses potential Rx-to-OTC switches.

Sheila Arquette, RPh, director of pharmacy services at Independent Health, discusses the lessons of high cost drugs such as PCSK9 inhibitors on specialty pharmacy.

Eric Peacock, CEO of MyHealthTeams, discusses effective treatment of patients with chronic conditions.

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses how the needs of specialty pharmacy, payers, and manufacturers can be aligned.

Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses high drug costs and the specialty pharmacy patient.

Rinku A. Patel, PharmD, RPh, discusses how to improve communication among patients, physicians, pharmacists, and payers.

Cheryl Allen, vice president of Industry Relations at Diplomat, discusses how specialty pharmacies can best position themselves to access limited distribution drugs.

Daniel P. Kus, BS Pharm, RPh, vice president of Pharmacy Advantage, discusses how specialty pharmacies will be impacted by the growth of accountable care organizations.

Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses how specialty pharmacies can help patients gain access to costly specialty drug regimens.

Erin Hohman, PharmD, BCPS, director of Clinical Pharmacy Services at Amber Pharmacy, discusses how communication can be improved among specialty pharmacies, manufacturers, and pharmacy benefit managers.